This is the first in a bimonthly series of articles about the personal alternative investments markets available to the professional corporate venturer. This new section in Global Corporate Venturing magazine looks beyond our readers’ day jobs at how they manage their time and wealth using the same skills of insight, trend analysis and managing risk they bring to their professional careers.
Month: March 2012
Profile: Robert Bosch Venture Capital
Acting as a magnet for entrepreneurs for Germany-based industrial parent Robert Bosch.
The evolving business of materials
Strategically-minded corporate partners with patience, experience and industry value-chain contacts, may be able to exploit a genuinely exciting opportunity.
Why and how corporations invest in clean-tech
Corporates investing in clean-tech often invest in the sector because they believe it is consistent with their core business.
Saab celebrates C3 sale success
Saab spins out ventures success story
Feature: Most influential industrials
Sector’s venturing activity gathers steam.
An IT company’s view on clean-tech
Intel Capital, the corporate venturing unit of chipmaker Intel, has been investing in clean-tech for five years.
Corporates converge for clean-tech long haul
The convergence of companies from the information technology sector with industrial and energy-focused incumbents is helping pick up some of the slack after a crisis of confidence has affected venture capital firms.
Industry seeks an end to a ‘volatile’ history
There remains continued growth of corporate venturing as it enters mainstream acceptance by companies around the world as a tool to help their innovation framework. One of the clearest examples that corporate venturing is in its golden age was the buoyant numbers of delegates at the 14th Annual Corporate Venturing and Innovation Partnering conference presented… Continue reading Industry seeks an end to a ‘volatile’ history
A potential route to riches
Bloomberg Ventures founder Lex Fenwick’s appointment as Dow Jones chief executive illustrates the potential of the industry as a springboard.
Deal round-up: February 2012
Deal-making subdued despite IPO recovery. To report a deal or add your data, email Toby Lewis at tlewis@globalcorporateventuring.com
4s3 Bioscience raises $20m from KLP
Genetic diseases company 4s3 Bioscience lands funding from a healthcare subsidiary of the family office of the wealthy Pritzker and Vlock families.
KBS&P follows on in first deal
The corporate venturing fund backed by Nasdaq-listed MDC Partners and Kirshenbaum Bond Senecal & Partners invests again in the near $5m series A round raised by Yieldbot, an advertising technology company.
Partminer divests business to IHS
Reed Elsevier Ventures, a backer of Partminer, said the divestment of a business by electronic components information source and supplier Partminer, demonstrates the ability of specific corporate venturing groups to rescue value.